RENAL AND METABOLIC EFFECTS OF CAFFEINE IN OBESE (fa/fa^cp), DIABETIC, HYPERTENSIVE ZSF1 RATS^*

REFERENCES

• Lamarine R J. Selected health and behavioral effects related to the use of caffeine. J Commun Health 1994; 19: 449–4966
   PubMed Web of Science ®Google Scholar
• Sowers J R, Lester M. Hypertension, hormones and aging. J Lab Clin Med 2000; 135: 379–386
   PubMed Web of Science ®Google Scholar
• Tofovic S P, Jackson E K. Effects of chronic caffeine consumption on renal function in Spontaneously Hypertensive Heart Failure Prone Rats. J Cardiovasc Pharmacol 1999; 33(3)360–366
   PubMed Web of Science ®Google Scholar
• Marks J B, Raskin P. Nephropathy and hypertension in diabetes. Med Clin North Am 1998; 82: 877–907
   PubMed Web of Science ®Google Scholar
• Sowers J R, Epstein M. Diabetes mellitus and associated hypertension, vascular disease and nephropathy. Hypertension 1995; 26: 869–879, An update
   PubMed Web of Science ®Google Scholar
• Hsueh W A, Buchanan T A. Obesity and Hypertension. Endocrinol Metabol Clin North Am 1994; 23: 406–427
   Web of Science ®Google Scholar
• Tofovic S P, Kost C, Li P, Jackson E K. Heart and kidney function in adult ZDFxSHHF Hybrid)-fa/facp rats. The FASEB Journal 1995; 9: A53, No.3 (Part I)
   Web of Science ®Google Scholar
• Tofovic S P, Kusaka I, Bastacky S. Renal function and structure in diabetic, hypertensive, obese ZDFx SHHF-hybrid rats. Renal Failure 2000a; 20(4)387–406
   Google Scholar
• Lowry O H, Rosebrough N J, Farr A L, Randall R J. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Tofovic S P, Kusaka H, Pfeifer S A, Jackson E K. Central Effects of Caffeine on Renal Renin Secretion and Norepinephrine Spillover. Journal of Cardiovascural Pharmacology 1996; 28: 302–313
   PubMed Web of Science ®Google Scholar
• Tofovic S P, Rominski R B, Bastacky S, Jackson E K, Kost C K., Jr. Caffeine augments proteinuriain puromycin- aminonucleoside nephrotic rats. Renal Failure 2000b; 20(2)159–180
   Google Scholar
• Tofovic S P, Branch K R, Oliver R D, Magee W D, Jackson E K. Caffeine potentiates vasodilator induced renin release. J Pharmacol Exp Ther 1991; 256: 850–860
   PubMed Web of Science ®Google Scholar
• Tofovic S P, Kusaka I, Rominski B, Jackson E K. Caffeine increases renal renin secretion in a rat model of genetic heart failure. J Cardiovasc Pharmacol 1999; 33: 440–450
   PubMed Web of Science ®Google Scholar
• Scislo T J, O'Leary D S. Activation of A2a adenosine receptors in the nucleus tractus solitarius inhibits renal but not lumbar sympathetic nerve activity. J Autonom Nervous Systen 1998; 68: 145–152
   PubMedGoogle Scholar
• Mosqueda-Garcia R, Killian T J, Haile V, Tseng C J, Robertson R M, Robertson D. Effects of caffeine on plasma catecholamines and muscle sympathetic nerve activity in man. Circulation 1990; 82: III–335
   Web of Science ®Google Scholar
• Kerr D, Sherwin b RS, Pavalkis K, Fayad P B, Sikorski L, Rife F, Tamborlane W V, During M J. Effects of caffeine on the recognition of and response to hypoglicemia in humans. Ann Int Med 1993; 119: 799–804
   PubMed Web of Science ®Google Scholar
• Campese V M, Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension 1995; 25: 878–882
   PubMed Web of Science ®Google Scholar
• Converse R L, Jacobsen T N, Toto R D, Jost C MT, Cosentino F, Fouard-Tarazzi F, Victor R G. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992; 327: 1912–1918
   PubMed Web of Science ®Google Scholar
• Katholi, et al, Katholi R E, Winternitz S R, Oparil S. Katholi et al. 1982,Importance of the renal nerves in established two-kidney, one- clip Golblatt hypertension. Hypertension 1982; 4(suppl.II)194, II-166-II 1982
   Google Scholar
• Huang W-C, Fang T-C, Cheng J-T. Renal denervation prevents and reverses hyperinsulinemia induced hypertension in rats. Hypertension 1998; 32: 249–254
   PubMed Web of Science ®Google Scholar
• Zhong Z, Connor H D, Yin M, Mason R P, Bunzendahl H, Froman D T, Thruman R G. Dietary glycine and renal denervation prevents cyclosporine A-induced hydroxyl radical production in rat kidney. Mol Pharmacology 1999; 56: 455–463
   PubMed Web of Science ®Google Scholar
• Amann K, Rump L C, Simonavience A, Oberhauser V, Wessels S, Orth S R, Gross M-L, Koch A, Bielenberg G W, Van Kats J P, Ehmke H, Mall G, Ritz E. Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats. J Am Soc Nephrol 2000; 11: 1469–1478
   PubMed Web of Science ®Google Scholar
• Green A, Newsholme E A. Sensitivity of glucose uptake and lipolysis of white adipocite of the rat to insulin and effects of some metabolites. Biochem J 1979; 180: 365–370
   PubMed Web of Science ®Google Scholar
• Espinal J, Challiss R AJ, Newsholme E A. Effects of adenosine deaminase and an adenosine analogues on insulin sensitivity in soleus muscle of the rats. FEBS Lett 1983; 158: 103–106
   PubMed Web of Science ®Google Scholar
• Budohoski L, Challiss R AJ, Mc Manus B, Newsholme E A. Effects of analogues of adnosine and methyl xanthines on insulin sensitivity in soleus muscle of the rat. FESB Lett 1984; 167: 1–4
   PubMed Web of Science ®Google Scholar
• Challis J RA, Budohoski L, Mc Manus B, Newsholme E A. Effects of an adenosine-receptor antagonist on insulin-resistance in soleus muscle from obese Zucker rats. Biochem J 1984; 221: 915–917
   PubMed Web of Science ®Google Scholar
• Budohoski L, Challiss R AJ, Lozeman F., McManus B., Newsholme E A. Reversal of dietary induced resistance in muscle of the rat by adenosine deaminase and an adenosine-receptor antagonist. Biochem J 1985; 224: 327–330
   Web of Science ®Google Scholar
• Xu B, Berkich D A, Crist G H, LaNoue K F. A1 adenosine receptor antagonism improves glucose tolerance in Zucker rats. Am J Physio 1998; 274: zE271–E279
   Google Scholar
• Crist G H, Xu B., Lanoue K F, Lang C H. Tissue-specific effects of in vivo adenosine receptor blockade on glucose uptake in Zucker rats. FASEB J 1998; 12: 1301–1380
   PubMed Web of Science ®Google Scholar
• Challiss R AJ, Lozeman F J, Leighton B, Newsholme E A. Effects of the beta-adrenoreceptor agonist isoprenaline on insulin sensitivity in soleus muscle of the rats. Biochem J 1986; 233: 337–381
   Web of Science ®Google Scholar
• Maron M B, Horvat S M, Wilkerson J E. Blood biochemical alterations during recovery from competitive marathon running. Eur J Appl Physiol 1977; 36: 231–235
   Web of Science ®Google Scholar
• Leduc J. Catecholamine production and release in exposure and acclimation to cold. Acta Physiol Scand 1961; 53(Suppl 183)1–44
   PubMedGoogle Scholar
• Challiss R AJ, Budohoski L, Newsholme E A, Sennitt M V, Cawthorme M A. Effect of a novel thermogenic bbeta-adrenoreceptor agonist (BRL 26830) on insulin resistance in soleus muscle from obese Zucker rats. Biochem Biophys Res Commun 1985; 128: 928–935
   PubMed Web of Science ®Google Scholar
• Thelle D S, Heyden S, Fodor J G. Coffee and cholesterol in epidemiological and experimental studies. Atherosclerosis 1987; 67: 97–103
   PubMed Web of Science ®Google Scholar
• Lewis C E, Caan B, Funkhouser E, Hilner J E, Bragg C, Dryer A, Raczynski J M, Savage P J, Armnstrong M A, Friedman G D. In consistent association of caffeine-containing beverages with blood pressure and with lipoproteins. Am J Epidemiol 1993; 138: 502–507
   PubMedGoogle Scholar
• Beynen A C, Weusten-Van der Wouw M P, de Roos B, Katan M B. Boiled coffee fails to raise serum cholesterol in hamsters and rats. Br J Nutrition 1996; 76: 755–764
   PubMed Web of Science ®Google Scholar
• Sammuelsson O, Mulec H, Knight G C, Attman P O, Kron B, Larsson R, Weiss L, Wedel H, Alaupovic P. Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant 1997; 12: 1908–1915
   PubMed Web of Science ®Google Scholar
• Lam K S, Cheng I K, Janus E D, Pang W R. (1995): Cholesterol-lowering therapy may retard the progression of diabetic nephropathy. Diabetologia 1995; 38: 604–609
   PubMed Web of Science ®Google Scholar
• Keane W F. Lipids and the kidney. Kidney Int 1994; 46: 910–920
   PubMed Web of Science ®Google Scholar
• Diamond J R, Karnovsky M J. A putative role of hypercholesterolemia in progressive glomerular injury. Annu Rev Med 1992; 43: 83–92
   PubMed Web of Science ®Google Scholar
• Toto R D, Grundy S M, Vega G L. Pravasatin treatment of very lod density intermediate density and low density lipoproteins in hypoercholesterolemia and combined hyperlipidemia secondary to nephrotic syndrome. Am J Nephrol 2000; 20: 12–17
   PubMed Web of Science ®Google Scholar
• O'Donnell M P, Kasiske B L, Kim Y, Schmitz P G, Keane W F. Lovastatin retards the progression of established glomerular indease in obese Zucker rats. Am J Kidney Dis 1993; 22: 83–89
   PubMed Web of Science ®Google Scholar
• O'Donnell M P, Keane W F. Lipid-lowering agents, renal function, and hypertensive disease in experimental models. Hypertension: Diagnosis and Management, J H Laragh, B M Brener. Raven Press, New York 1995; 1521–1537
   Google Scholar